Open access to any company across three categories: Formulation, Process Development and Best Packaging
CPhI Worldwide, organised by UBM Live, has issued a call for entries to the annual CPhI Pharma Awards. For the first time the awards are now open to the entire pharma industry and will celebrate the most innovative and dynamic areas across the global community. The Awards recognise thought leadership on a global scale, unveiling top pharma innovators to global trade.
The awards honour companies that are driving forward industry-changing initiatives across innovation within three broad categories – Formulation, Process Development and Packaging. The CPhI Worldwide 2013 exhibition runs from 22-24 October at the Messe Frankfurt, and winners of the CPhI Pharma Awards will be announced at a ceremony during the evening on 22 October.
CPhI is now accepting applications for the 2013 CPhI Pharma Awards, open to individuals and companies that have developed innovations in pharma over the past year. If you or your company has an innovation in pharma that you believe should be recognised, you can learn more about the awards or submit an award entry at www.cphi.com/pharma-awards.
‘The CPhI Pharma Awards are the ideal opportunity to present exciting, breakthrough innovations to the pharmaceutical industry. We are proud to be entering our tenth year of running the awards to acknowledge and recognise the sheer determination and efforts that companies pour into their work,’ said Andrew Pert, Pharma Brand Director.
‘This year we have three categories and there will be one winner for each: Best Innovation in Formulation; Best Innovation in Process Development; and Best Innovation in Packaging. Not only do companies receive the recognition that they deserve for their outstanding innovations, but entry into the Pharma Awards also gives unrivalled exposure to the media, while raising company profiles among key pharmaceutical industry professionals and VIPs.’
Last year at the Feria de Madrid in Spain, Haemopharm Healthcare was awarded gold in the Best Innovation category for its needle-free vial closure designed to connect a syringe and vial without any further components, thereby facilitating easier administration of parenteral drugs. Merck Millipore took silver for its drug delivery platform using silica, which takes full advantage of the large surface area and good transport properties that silica possesses. The bronze award was won by BioClin for its Multi-Oral Remin remineralisation gel for application in the oral cavity - a self-care product especially suitable for people that regularly take medication.
‘Our winning at the CPhI Pharma Awards has enhanced our presence not only at the show but also to all of our contacts, while giving us a great exposure and visibility within the pharmaceutical trade media - magazines and websites - as well as in the medical devices field, bringing interesting and fruitful business and co-operation opportunities,’ said Dana Barocas, Marketing Communications manager of Haemopharm.
Entries are now open to both CPhI Worldwide exhibitors and visitors, as well as the wider pharma community through to Friday 26 July. After the deadline the jury panel will meet to select the finalists for each category; the panel includes senior figures from companies including CU Chemie Uetikon, Merck & Cie and PharmAccel Consulting. Finalists will present their innovations during the morning of the first show day to the jury, press and visitors. The winners will then be formally announced during the awards ceremony and reception taking place the same evening at the Messe Frankfurt Europa Room.